Noviga Research

Noviga Research is a company developing a cancer treatment medications. Its anti-cancer compound NOV202 can be used to extend patients' life. The medication can be used for ovarian epithelial, breast, and lung cancer patients. In addition, the company's Bromodomains (BRD) project is aimed to create pharmacological therapy against neoplastic, viral, neurological, inflammatory and autoimmune disorders.